Header Logo

Connection

Glenda Gray to Humans

Back to Details
This is a "connection" page, showing publications Glenda Gray has written about Humans.
Glenda Gray
Connection Strength
1,933
Humans
  1. COVID-19 as a catalyst for vaccine manufacturing: A South African experience. Cell Host Microbe. 2023 06 14; 31(6):839-842.
    View in: PubMed
    Score: 0,066
  2. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa. PLoS One. 2021; 16(7):e0255124.
    View in: PubMed
    Score: 0,058
  3. Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. N Engl J Med. 2021 03 25; 384(12):1089-1100.
    View in: PubMed
    Score: 0,056
  4. Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa. PLoS One. 2020; 15(10):e0241014.
    View in: PubMed
    Score: 0,055
  5. Review of preventative HIV vaccine clinical trials in South Africa. Arch Virol. 2020 Nov; 165(11):2439-2452.
    View in: PubMed
    Score: 0,054
  6. Level of adult client satisfaction with clinic flow time and services of an integrated non-communicable disease-HIV testing services clinic in Soweto, South Africa: a cross-sectional study. BMC Health Serv Res. 2020 May 11; 20(1):404.
    View in: PubMed
    Score: 0,053
  7. Demographics and health profile on precursors of non-communicable diseases in adults testing for HIV in Soweto, South Africa: a cross-sectional study. BMJ Open. 2019 12 15; 9(12):e030701.
    View in: PubMed
    Score: 0,052
  8. HIV research in South Africa: Advancing life. S Afr Med J. 2019 Dec 05; 109(11b):36-40.
    View in: PubMed
    Score: 0,051
  9. Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa. Sci Transl Med. 2019 09 18; 11(510).
    View in: PubMed
    Score: 0,051
  10. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study. PLoS One. 2017; 12(12):e0188606.
    View in: PubMed
    Score: 0,045
  11. Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection. PLoS One. 2017; 12(10):e0184775.
    View in: PubMed
    Score: 0,044
  12. Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap. Clin Vaccine Immunol. 2016 06; 23(6):496-506.
    View in: PubMed
    Score: 0,040
  13. Approaches to preventative and therapeutic HIV vaccines. Curr Opin Virol. 2016 04; 17:104-109.
    View in: PubMed
    Score: 0,040
  14. Exposure to and experiences of violence among adolescents in lower socio-economic groups in Johannesburg, South Africa. BMC Public Health. 2015 May 01; 15:450.
    View in: PubMed
    Score: 0,037
  15. Impact of exposure to intimate partner violence on CD4+ and CD8+ T cell decay in HIV infected women: longitudinal study. PLoS One. 2015; 10(3):e0122001.
    View in: PubMed
    Score: 0,037
  16. Kganya Motsha Adolescent Centre: a model for adolescent friendly HIV management and reproductive health for adolescents in Soweto, South Africa. AIDS Care. 2015; 27(6):697-702.
    View in: PubMed
    Score: 0,037
  17. Support for relactation among mothers of HIV-infected children: a pilot study in Soweto. Breastfeed Med. 2014 Nov; 9(9):450-7.
    View in: PubMed
    Score: 0,036
  18. Reevaluating HIV vaccine clinical trials policy for infants. J Infect Dis. 2015 Feb 15; 211(4):501-3.
    View in: PubMed
    Score: 0,036
  19. Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses. PLoS One. 2014; 9(8):e103446.
    View in: PubMed
    Score: 0,036
  20. Correlates of sexual risk among sexual minority and heterosexual South African youths. Am J Public Health. 2014 Jul; 104(7):1265-9.
    View in: PubMed
    Score: 0,035
  21. Predictors of parent-adolescent communication in post-apartheid South Africa: a protective factor in adolescent sexual and reproductive health. J Adolesc. 2014 Apr; 37(3):313-24.
    View in: PubMed
    Score: 0,035
  22. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis. 2014 May; 14(5):388-96.
    View in: PubMed
    Score: 0,034
  23. Factors associated with not testing for HIV and consistent condom use among men in Soweto, South Africa. PLoS One. 2013; 8(5):e62637.
    View in: PubMed
    Score: 0,033
  24. Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? Vaccine. 2013 Apr 12; 31(16):2089-96.
    View in: PubMed
    Score: 0,032
  25. Conversations with mothers: exploring reasons for prevention of mother-to-child transmission (PMTCT) failures in the era of programmatic scale-up in Soweto, South Africa. AIDS Behav. 2012 Jan; 16(1):91-8.
    View in: PubMed
    Score: 0,030
  26. Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa. J Acquir Immune Defic Syndr. 2011 Oct 01; 58(2):211-8.
    View in: PubMed
    Score: 0,029
  27. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis. 2011 Jul; 11(7):507-15.
    View in: PubMed
    Score: 0,028
  28. Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS. 2010 Sep; 5(5):357-61.
    View in: PubMed
    Score: 0,027
  29. Adolescent HIV--cause for concern in Southern Africa. PLoS Med. 2010 Feb 02; 7(2):e1000227.
    View in: PubMed
    Score: 0,026
  30. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav. 2009 Jun; 13 Suppl 1:47-54.
    View in: PubMed
    Score: 0,025
  31. Pain in women with HIV/AIDS. Pain. 2007 Nov; 132 Suppl 1:S13-S21.
    View in: PubMed
    Score: 0,022
  32. HIV and pregnancy. BMJ. 2007 May 05; 334(7600):950-3.
    View in: PubMed
    Score: 0,022
  33. Immune-based prevention of mother-to-child HIV-1 transmission. Curr Opin Mol Ther. 2007 Apr; 9(2):168-75.
    View in: PubMed
    Score: 0,021
  34. Effect of HIV on women. AIDS Read. 2006 Jul; 16(7):365-8, 373-7.
    View in: PubMed
    Score: 0,020
  35. Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants. J Acquir Immune Defic Syndr. 2006 Jun; 42(2):169-76.
    View in: PubMed
    Score: 0,020
  36. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005 Aug 12; 19(12):1289-97.
    View in: PubMed
    Score: 0,019
  37. Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024 Feb 27; 42(6):1195-1199.
    View in: PubMed
    Score: 0,017
  38. Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. PLoS Pathog. 2023 Nov; 19(11):e1011772.
    View in: PubMed
    Score: 0,017
  39. Laboratory services in the context of prevention of mother-to-child transmission of HIV testing requirements in Copperbelt Province, Zambia: a qualitative inquiry. BMC Health Serv Res. 2023 Jul 14; 23(1):753.
    View in: PubMed
    Score: 0,017
  40. Health system response to preventing mother-to-child transmission of HIV policy changes in Zambia: a health system dynamics analysis of primary health care facilities. Glob Health Action. 2022 12 31; 15(1):2126269.
    View in: PubMed
    Score: 0,016
  41. What can we do to reduce mother to child transmission of HIV? BMJ. 2002 Jan 26; 324(7331):218-21.
    View in: PubMed
    Score: 0,015
  42. HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):376-383.
    View in: PubMed
    Score: 0,015
  43. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
    View in: PubMed
    Score: 0,014
  44. Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial. PLoS One. 2021; 16(1):e0241708.
    View in: PubMed
    Score: 0,014
  45. Community-led cross-sectional study of social and employment circumstances, HIV and associated factors amongst female sex workers in South Africa: study protocol. Glob Health Action. 2021 01 01; 14(1):1953243.
    View in: PubMed
    Score: 0,014
  46. High cellphone use associated with greater risk of depression among young women aged 15-24 years in Soweto and Durban, South Africa. Glob Health Action. 2021 01 01; 14(1):1936792.
    View in: PubMed
    Score: 0,014
  47. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important. BMC Public Health. 2020 Nov 07; 20(1):1669.
    View in: PubMed
    Score: 0,014
  48. Almost 1 in 5 South African adults have chronic pain: a prevalence study conducted in a large nationally representative sample. Pain. 2020 07; 161(7):1629-1635.
    View in: PubMed
    Score: 0,013
  49. COVID-19 lockdowns in low- and middle-income countries: Success against COVID-19 at the price of greater costs. S Afr Med J. 2020 06 19; 110(8):724-726.
    View in: PubMed
    Score: 0,013
  50. COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health. 2020 05 15; 16(1):46.
    View in: PubMed
    Score: 0,013
  51. A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa. PLoS One. 2020; 15(4):e0231086.
    View in: PubMed
    Score: 0,013
  52. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines. PLoS Med. 2020 02; 17(2):e1003038.
    View in: PubMed
    Score: 0,013
  53. Pain in Clients Attending a South African Voluntary Counseling and Testing Center Was Frequent and Extensive But Did Not Depend on HIV Status. J Acquir Immune Defic Syndr. 2020 02 01; 83(2):181-188.
    View in: PubMed
    Score: 0,013
  54. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ. 1999 Jun 19; 318(7199):1650-6.
    View in: PubMed
    Score: 0,012
  55. "It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis. AIDS Behav. 2018 Nov; 22(11):3692-3704.
    View in: PubMed
    Score: 0,012
  56. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
    View in: PubMed
    Score: 0,012
  57. Depression and Post Traumatic Stress amongst female sex workers in Soweto, South Africa: A cross sectional, respondent driven sample. PLoS One. 2018; 13(7):e0196759.
    View in: PubMed
    Score: 0,012
  58. Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa. AIDS Behav. 2018 Jul; 22(7):2312-2321.
    View in: PubMed
    Score: 0,012
  59. Perceptions of counsellors and youth-serving professionals about sexual and reproductive health services for adolescents in Soweto, South Africa. Reprod Health. 2018 Feb 06; 15(1):21.
    View in: PubMed
    Score: 0,011
  60. A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa. PLoS One. 2017; 12(7):e0180645.
    View in: PubMed
    Score: 0,011
  61. Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country. Clin Diagn Virol. 1997 May; 8(1):1-8.
    View in: PubMed
    Score: 0,011
  62. Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). J Acquir Immune Defic Syndr. 2017 02 01; 74(2):158-165.
    View in: PubMed
    Score: 0,011
  63. The association between HIV, antiretroviral therapy, and gestational diabetes mellitus. AIDS. 2017 01 02; 31(1):113-125.
    View in: PubMed
    Score: 0,011
  64. Prevalence and patterns of victimization and polyvictimization among female sex workers in Soweto, a South African township: a cross-sectional, respondent-driven sampling study. Glob Health Action. 2017; 10(1):1403815.
    View in: PubMed
    Score: 0,011
  65. Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes. Pediatr Infect Dis J. 2016 Aug; 35(8):894-900.
    View in: PubMed
    Score: 0,010
  66. Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012. BMC Public Health. 2016 Apr 14; 16:330.
    View in: PubMed
    Score: 0,010
  67. The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis. Medicine (Baltimore). 2016 Jan; 95(4):e2528.
    View in: PubMed
    Score: 0,010
  68. Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr. 2015 Aug 01; 69(4):430-8.
    View in: PubMed
    Score: 0,010
  69. Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J. 2015 Mar; 34(3):e52-7.
    View in: PubMed
    Score: 0,009
  70. Health-seeking behaviours by gender among adolescents in Soweto, South Africa. Glob Health Action. 2015; 8:25670.
    View in: PubMed
    Score: 0,009
  71. Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans. Infect Genet Evol. 2015 Mar; 30:147-158.
    View in: PubMed
    Score: 0,009
  72. Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa. PLoS One. 2014; 9(11):e112303.
    View in: PubMed
    Score: 0,009
  73. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort. PLoS One. 2014; 9(5):e96369.
    View in: PubMed
    Score: 0,009
  74. CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention. PLoS One. 2014; 9(3):e90754.
    View in: PubMed
    Score: 0,009
  75. The effect of a maturing antiretroviral program on early mortality for patients with advanced immune-suppression in Soweto, South Africa. PLoS One. 2013; 8(11):e81538.
    View in: PubMed
    Score: 0,008
  76. KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. Clin Immunol. 2013 Dec; 149(3):498-508.
    View in: PubMed
    Score: 0,008
  77. Does routine prophylactic oral flucloxacillin reduce the incidence of post-circumcision infections? Am J Infect Control. 2013 Oct; 41(10):897-900.
    View in: PubMed
    Score: 0,008
  78. Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. Int J STD AIDS. 2012 Oct; 23(10):e10-3.
    View in: PubMed
    Score: 0,008
  79. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS. 2011 Jan 02; 25(1):87-94.
    View in: PubMed
    Score: 0,007
  80. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis. 2010 Nov 01; 202(9):1444-53.
    View in: PubMed
    Score: 0,007
  81. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med. 2009 Oct; 6(10):e1000172.
    View in: PubMed
    Score: 0,006
  82. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberc Lung Dis. 2009 Jul; 13(7):862-7.
    View in: PubMed
    Score: 0,006
  83. Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP-1alpha) chemokine: implications for HIV-1 infection. Int J Immunogenet. 2009 Feb; 36(1):21-32.
    View in: PubMed
    Score: 0,006
  84. Comparative costs of inpatient care for HIV-infected and uninfected children and adults in Soweto, South Africa. J Acquir Immune Defic Syndr. 2007 Dec 01; 46(4):410-6.
    View in: PubMed
    Score: 0,006
  85. Development of a whole blood intracellular cytokine staining assay for mapping CD4(+) and CD8(+) T-cell responses across the HIV-1 genome. J Virol Methods. 2007 Sep; 144(1-2):115-21.
    View in: PubMed
    Score: 0,005
  86. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol. 2007 Apr; 14(4):348-54.
    View in: PubMed
    Score: 0,005
  87. Clinical significance and etiology of infected catheters used for total parenteral nutrition. Surg Gynecol Obstet. 1986 Nov; 163(5):469-74.
    View in: PubMed
    Score: 0,005
  88. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr. 2006 Aug 15; 42(5):545-53.
    View in: PubMed
    Score: 0,005
  89. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):379-81.
    View in: PubMed
    Score: 0,005
  90. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol. 2006 Jul; 87(Pt 7):2055-2065.
    View in: PubMed
    Score: 0,005
  91. High rates of HIV in surgical patients in Soweto, South Africa: impact on resource utilisation and recommendations for HIV testing. Trans R Soc Trop Med Hyg. 2007 Feb; 101(2):176-82.
    View in: PubMed
    Score: 0,005
  92. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004 Oct 01; 173(7):4607-17.
    View in: PubMed
    Score: 0,004
  93. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS. 2003 Jun 13; 17(9):1398-400.
    View in: PubMed
    Score: 0,004
  94. Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes. 2003 Jan; 26(1):49-56.
    View in: PubMed
    Score: 0,004
  95. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr. 2000 08; 46(4):224-30.
    View in: PubMed
    Score: 0,003
  96. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J. 1999 Sep; 18(9):800-5.
    View in: PubMed
    Score: 0,003
  97. Prostaglandins in the treatment of reflux oesophagitis: double-blind placebo controlled clinical trial. J R Coll Surg Edinb. 1991 Aug; 36(4):216-8.
    View in: PubMed
    Score: 0,002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.